Mpox
📧 Sign up to get email alerts when something new happens for Mpox.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC [Phase 3]
Phase 3 infant safety and immunogenicity trial of MVA-BN in the Democratic Republic of Congo is active not recruiting for mpox vaccination i…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Study of Tecovirimat for Human Mpox Virus [Phase 3]
Phase 3 study of tecovirimat for mpox has been terminated; results have been posted (2026-02-10).
-
CLINICAL_TRIALS trial_result · 2025-07-16Clinical Trial Update: A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age [Phase 1, Phase 2]
The study reports the completion of a Phase 1/2 trial evaluating the safety, tolerability, and immune response of multiple doses of the inve…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Break-through Infection Following Mpox vaccinatIon
A completed clinical trial update reports a breakthrough mpox infection occurring after mpox vaccination.